Plotkin Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-3,618
Closed -$335K – 93
2021
Q2
$335K Sell
3,618
-21,984
-86% -$1.87M 0.19% 70
2021
Q1
$2.27M Buy
25,602
+22,009
+613% +$2.18M 1.39% 25
2020
Q4
$335K Buy
+3,593
New +$286K 0.22% 47

Other funds holding ARKG

Plotkin Financial Advisors's ARKG Position: Q3 2021 in Review

Plotkin Financial Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 3,618 shares — an estimated $335K sold.

Plotkin Financial Advisors first reported a position in ARKG in Q4 2020 and held it in 3 quarters. The position peaked at $2.27M in Q1 2021. 470 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

  • Plotkin Financial Advisors reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
  • Plotkin Financial Advisors sold 3,618 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $335K.
  • Plotkin Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 3 quarters.
  • Plotkin Financial Advisors's ARK Genomic Revolution ETF position peaked at $2.27M in Q1 2021.
  • 470 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Plotkin Financial Advisors's 13F filing for Q3 2021, filed 15 Nov 2024.